Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:09 AM
Ignite Modification Date:
2025-12-25 @ 2:09 AM
NCT ID:
NCT00135460
Eligibility Criteria:
Inclusion Criteria:
* Antiretroviral naïve patients
* HIV-1 infection as documented by a licensed HIV-1 antibody ELISA.
* Fulfilling the criteria for starting antiretroviral therapy.
* Ability to understand and provide written informed consent.
Exclusion Criteria:
* Women being pregnant or breast-feeding.
* Fertile women using no safe contraception.
* Patients with active intravenous drug use.
* Abuse of alcohol, which in the opinion of the treating physician will reduce the patient´s ability to follow a therapeutic regimen and evaluations of the protocol.
* Ongoing medical treatment, which has a clinically significant interaction with lopinavir, ritonavir or efavirenz.
* Creatinine \> 200 mmol/l.
* ALT or AST \> 5 times upper normal value (200U/l).
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00135460
Study Brief:
Protocol Section:
NCT00135460